<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010038253">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Jaimovich, E.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Mattei, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Liberona, J. L.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Cardenas, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Estrada, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Barbier, J.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Debitus, Cécile</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Laurent, Dominique</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Molgo, J.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells</title>
        <secondary-title>Febs Letters</secondary-title>
      </titles>
      <pages>2051-2057</pages>
      <keywords>
        <keyword>INVERTEBRE AQUATIQUE</keyword>
        <keyword>SUBSTANCE NATURELLE</keyword>
        <keyword>ALCALOIDE</keyword>
        <keyword>STRUCTURE CHIMIQUE</keyword>
        <keyword>ACTIVITE BIOLOGIQUE</keyword>
        <keyword>INTERET PHARMACOLOGIQUE</keyword>
        <keyword>CULTURE CELLULAIRE</keyword>
        <keyword>TEST</keyword>
        <keyword>XESTOSPONGIN B</keyword>
        <keyword>EPONGE</keyword>
        <keyword>xestospongin B</keyword>
        <keyword>inositol 1,4,5 trisphosphate</keyword>
        <keyword>intracellular Ca2+ signals</keyword>
        <keyword>bradykinin</keyword>
        <keyword>neuroblastoma NG108 15 cell</keyword>
        <keyword>rat skeletal myotubes</keyword>
        <keyword>cerebellar membranes</keyword>
        <keyword>isolated myonuclei</keyword>
        <keyword>calcium ATPase</keyword>
        <keyword>NOUVELLE CALEDONIE</keyword>
      </keywords>
      <dates>
        <year>2005</year>
      </dates>
      <call-num>fdi:010038253</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Febs Letters</full-title>
      </periodical>
      <isbn>0014-5793</isbn>
      <accession-num>CC:0002283107-0006</accession-num>
      <number>10</number>
      <electronic-resource-num>10.1016/j.febslet.2005.02.053</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010038253</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2024-12/010038253.pdf</url>
        </pdf-urls>
      </urls>
      <volume>579</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Xestospongin B, a macrocyclic bis-1-oxaquinolizidine alkaloid extracted from the marine sponge Xestospongia exigua, was highly purified and tested for its ability to block inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release. In a concentration-dependent manner xestospongin B displaced [H-3]IP3 from both rat cerebellar membranes and rat skeletal myotube homogenates with an EC50 of 44.6 +/- 1.1 mu M and 27.4 +/- 1.1 mu M, respectively. Xestospongin B, depending on the dose, suppressed bradykinin-induced Ca2+ signals in neuroblastoma (NG108-15) cells, and also selectively blocked the slow intracellular Ca2+ signal induced by membrane depolarization with high external K+ (47mM) in rat skeletal myotubes. This slow Ca2+ signal is unrelated to muscle contraction, and involves IP3 receptors. In highly purified isolated nuclei from rat skeletal myotubes, Xestospongin B reduced, or suppressed IP3-induced Ca2+ oscillations with an EC50 = 18.9 +/- 1.35 mu M. In rat my rotubes exposed to a Ca2+-free medium, Xestospongin B neither depleted sarcoplasmic reticulum Ca2+ stores, nor modified thapsigargin action and did not affect capacitative Ca2+ entry after thapsigargin-induced depletion of Ca2+ stores. Ca2+-ATPase activity measured in skeletal myrotube homogenates remained unaffected by Xestospongin B. It is concluded that xestospongin B is an effective cell-permeant. competitive inhibitor of IP3 receptors in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.</abstract>
      <custom6>035SUBSAN02</custom6>
    </record>
  </records>
</xml>
